XETRA · BNN.DE
BRAIN Biotech AG
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
Loading market information…
XETRA · GME.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Geratherm Medical AG’s quoted price sits in the lower half of its reported 52-week range, 55.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Geratherm Medical AG’s forward annual dividend is €0.10 per share, paid annual. The forward yield is 4.74% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Geratherm Medical AG’s next earnings report is currently expected on Apr 27, 2027, with estimated earnings per share of -€0.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Geratherm Medical AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Geratherm Medical AG, a German-based medical technology enterprise, organizes its operations across four primary divisions: Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems. The Healthcare Diagnostic unit offers a range of items including clinical thermometers, blood pressure monitors, and various self-test diagnostic products designed for women, such as pregnancy tests, chlamydia screens, urinary tract infection indicators, diverse ovulation solutions, and pH tests. Its Respiratory segment is dedicated to the development and production of equipment primarily for diagnosing pulmonary and cardiopulmonary function. Under the LMT brand, the Medical Warming Systems division manufactures MRI-compatible incubators for premature and newborn infants. The Cardio/Stroke segment provides analytical products aimed at assessing stroke risk by detecting atrial fibrillation. The company markets its healthcare solutions via pharmacies, hospitals, and clinics, and successfully exports its merchandise to approximately 60 nations worldwide. Established in 1990, Geratherm Medical AG's headquarters are situated in Geschwenda, Germany.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Jun 20, 2024 |
| €0.08 |
| €9.50M |
| Q3 2023 | Dec 31, 2023 | €0.04 | €4.89M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€2.78+€0.22 (+8.59%)
BRAIN Biotech AG’s quoted price sits in the lower half of its reported 52-week range, 28.53% below the high.
€10.50€0.00 (0.0%)
DocCheck AG’s quoted price sits in the lower half of its reported 52-week range, 33.96% below the high.
€20.20+€0.20 (+1.0%)
MeVis Medical Solutions AG’s quoted price sits in the lower half of its reported 52-week range, 24.63% below the high.
€1.64+€0.06 (+3.81%)
NanoRepro AG’s quoted price sits in the lower half of its reported 52-week range, 31.88% below the high.
€1.48€0.00 (0.0%)
aap Implantate AG’s quoted price sits in the lower half of its reported 52-week range, 36.75% below the high.
€0.92+€0.08 (+9.58%)
Maternus-Kliniken AG’s quoted price sits in the lower half of its reported 52-week range, 91.61% below the high.
€7.40-€0.45 (-5.73%)
AS Latvijas Juras medicinas centrs’s quoted price sits in the lower half of its reported 52-week range, 19.57% below the high.
€0.28-€0.01 (-3.45%)
SynBiotic SE’s quoted price sits in the lower half of its reported 52-week range, 92.73% below the high.
